Population Structure of Staphylococcus aureus from Remote African Babongo Pygmies by Schaumburg, Frieder et al.
Population Structure of Staphylococcus aureus from
Remote African Babongo Pygmies
Frieder Schaumburg
1,2*, Robin Ko ¨ck
1,3, Alexander W. Friedrich
3, Solange Soulanoudjingar
2,4, Ulysse
Ateba Ngoa
2,4, Christof von Eiff
1,5, Saadou Issifou
2,4, Peter G. Kremsner
2,4, Mathias Herrmann
6, Georg
Peters
1, Karsten Becker
1
1Institute of Medical Microbiology, University of Mu ¨nster, Mu ¨nster, Germany, 2Medical Research Unit, Albert Schweitzer Hospital, Lambare ´ne ´, Gabon, 3Institute of
Hygiene, University of Mu ¨nster, Mu ¨nster, Germany, 4Institute of Tropical Medicine, University of Tu ¨bingen, Tu ¨bingen, Germany, 5Pfizer Pharma GmbH, Berlin, Germany,
6Institute of Medical Microbiology and Hygiene, University of Saarland, Homburg, Germany
Abstract
Background: Pandemic community-acquired methicillin-resistant Staphylococcus aureus isolates (CA-MRSA) predominantly
encode the Panton-Valentine leukocidin (PVL), which can be associated with severe infections. Reports from non-indigenous
Sub-Saharan African populations revealed a high prevalence of PVL-positive isolates. The objective of our study was to
investigate the S. aureus carriage among a remote indigenous African population and to determine the molecular
characteristics of the isolates, particularly those that were PVL-positive.
Methodology/Principal Findings: Nasal S. aureus carriage and risk factors of colonization were systematically assessed in
remote Gabonese Babongo Pygmies. Susceptibility to antibiotics, possession of toxin-encoding genes (i.e., PVL,
enterotoxins, and exfoliative toxins), S. aureus protein A (spa) types and multi-locus sequence types (MLST) were
determined for each isolate. The carriage rate was 33%. No MRSA was detected, 61.8% of the isolates were susceptible to
penicillin. Genes encoding PVL (55.9%), enterotoxin B (20.6%), exfoliative toxin D (11.7%) and the epidermal cell
differentiation inhibitor B (11.7%) were highly prevalent. Thirteen spa types were detected and were associated with 10 STs
predominated by ST15, ST30, ST72, ST80, and ST88.
Conclusions: The high prevalence of PVL-positive isolates among Babongo Pygmies demands our attention as PVL can be
associated with necrotinzing infection and may increase the risk of severe infections in remote Pygmy populations. Many S.
aureus isolates from Babongo Pygmies and pandemic CA-MRSA-clones have a common genetic background. Surveillance is
needed to control the development of resistance to antibiotic drugs and to assess the impact of the high prevalence of PVL
in indigenous populations.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as
a community-acquired pathogen in many countries throughout
the world (community-acquired MRSA, CA-MRSA). CA-MRSA
mostly causes skin or soft-tissue infections as well as deep-seated
infections such as necrotizing pneumonia. Predominantly, CA-
MRSA encodes the Panton-Valentine Leukocidin (PVL), a S.
aureus exotoxin that induces lysis of monocytes and neutrophil
granulocytes [1]. In African countries, the occurrence of CA-
MRSA has been reported previously from Egypt [2], Mali [3],
Algeria [4] and Nigeria [5].
Interestingly, population analysis of global methicillin-susceptible
S. aureus (MSSA) isolates associated with PVL have recently
indicated that PVL-positive MSSA and MRSA are phylogenetically
related based on molecular epidemiological profiles and are
dynamically interrelating [6]. Moreover, it was shown, that PVL-
positive MSSA are a likely reservoir for the development of PVL-
positive MRSA [6] via integration of Staphylococcus cassette
chromosome mec (SCCmec) elements including the mecA gene
conferring methicillin resistance. Indeed, it is striking that reports
from African countries have recently described a high prevalence of
PVL-positive MSSA isolates in Nigeria [7] and Mali [3] and have
supported the hypothesis that at least one common European
MRSA clone associated with PVL (sequence type ST152 according
to multilocussequencetyping(MLST))could originate from African
MSSA clones [3]. Interestingly, a study on S. aureus colonization in
Wayampi Amerindians in French Guiana revealed a predominance
of ST1223 which is highly divergent from other global STs [8].
Ruimy et al. hypothesize, that this association of highly divergent
clones in an isolated remote population may reflect the co-evolution
of humans and S. aureus as well as human migration [8,9].
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Africa’’ hypothesis, as shown for Helicobacter pylori [10], might also
be true for PVL-positive S. aureus clones now emerging across the
globe. To address this question, we aimed to collect systematically
S. aureus isolates independent from the healthcare setting, which is
associated with the dissemination of isolates adapted to the specific
selection pressure of the hospital environment. Therefore, we
performed a cross-sectional S. aureus carrier study among the
indigenous Pygmy population in Gabon. One to five percent of the
Gabonese population is comprised by Pygmy hunter-gatherers.
Almost 50% belong to the Babongo tribe, most of them are living
in Waka National Parc, Central Gabon.
Materials and Methods
Ethics statement
Ethical clearance was obtained from our institutional review
board (IRB, ‘‘Comite ´ d’E ´thique Re ´gional Inde ´pendant de
Lambare ´ne ´’’, Lambare ´ne ´, Gabon, protocol number: CERIL 15–
09). As the majority of Babongos are illiterate and mainly speak
the tribal language, we involved a local interpreter to provide
detailed information about the study and to obtain a documented
oral informed consent. We prepared a short written summary in
French that described the information presented to the Pygmies.
This document was signed or finger-printed by the participant, the
researcher and a witness who spoke French and Babongo. The
IRB approved the use of documented oral informed consent.
Study population
A cross-sectional survey of S. aureus nasal carriage in Babongo
Pygmies was conducted as part of the German-African network on
staphylococci and staphylococcal diseases (DFG PAK 296) and
took place in the Ikobe ´ region, Central Gabon in November 2009.
All Babongo or mixed Babongo-Bantu inhabitants of the Ikobe ´
region were included if they provided a documented informed
consent. Exclusion criteria were (i) infections of nostrils and (ii) a
purulent rhinitis. Demographic data (self reported age, height,
weight, sex and ethnic group) were recorded for each subject.
Travel habits since birth and daily activities were recorded to
assess risk factors for S. aureus carriage. Global positioning data of
each village were taken by GPS-device (Garmin76 csx).
Bacterial isolates
Nasal swabs were stored in cool boxes and inoculated on SAID
agar plates (bioMe ´rieux, Marcy l’Etoile, France) and Columbia
blood agar plates in the laboratory facilities of the Medical
Research Unit, Lambare ´ne ´ within four days after sampling.
Presumptive S. aureus isolates were identified by colony character-
istics, catalase and latex agglutination test (Pastorex Staph-Plus,
Bio-Rad Laboratories, Marnes-la-Coquette, France). Species
identification and antibiotic susceptibility testing were performed
by Vitek 2 automated systems (bioMe ´rieux, Marcy l’Etoile,
France). Molecular confirmation of S. aureus and determination
of methicillin-resistance were performed as described [11]. To
confirm susceptibility to penicillin, a blaZ PCR targeting the S.
aureus penicillinase was performed additionally [12].
Virulence factors, capsular polysaccharides and agr
subtypes
Panton-Valentine leukocidin (PVL) encoding genes (lukS-PV,
lukF-PV) were detected [13]. Staphylococcal pyrogenic toxin
superantigens (PTSAgs) were analyzed by detecting toxic shock
syndrome toxin (TSST-1) encoding genes (tst) and the enterotoxins
(sea, seb, sec, sed, see, seg, seh, sei and sej) [14,15]. Exfoliative toxins (eta,
etb and etd) and genes encoding members of the epidermal cell
differentiation inhibitor (edin-A, edin-B and edin-C) were detected by
gene amplification [14–17].
Capsular polysaccharide types 5 and 8 and accessory gene
regulator subtypes (agr I–IV) were identified by multiplex PCR
approaches [13,18].
Genotyping
S. aureus isolates were typed based on sequencing of the
hypervariable region of the S. aureus protein A gene (spa), spa types
were assigned on the Ridom SpaServer (http://spaserver.ridom.
de) curated by the SeqNet.org initiative [19]. Multilocus sequence
typing (MLST) was carried out for each isolate [20]. Relatedness
in allelic profiles was assessed using eBURST (version 3, http://
eburst.mlst.net). To affiliate the S. aureus sequence types (STs) of
the Pygmy population to known clonal complexes (CC), we
compared our dataset with the whole MLST database of S. aureus
using the stringent group definition of a minimum of 6/7 shared
alleles.
Statistics
Proportions of categorical variables were tested using Chi-
square test and Fisher’s exact test, where appropriate. Odds-ratio
and the 95% confidence intervals were calculated to test for
associations. The level of significance was a=5%. All analyses
were performed using the software ‘‘R’’ (http://cran.r-project.org,
Version: 2.10.1) and package ‘‘epicalc’’.
Results
Study population
Nasal swabs were obtained from 99 Babongo Pygmies and 1
Babongo-Mitsogho living in the Ikobe ´ region, Gabon. Study
participants came from five camp-like villages (GPS coordinates in
brackets) made up of about six to ten huts: ‘‘Village Tranquille’’
(S1u02.3929; E11u03.7449), ‘‘Tsibanga’’ (S1u02.5779; E11u05.6619),
‘‘Ossimba’’ (S1u02.4339; E11u04.6559), ‘‘Ndougou’’ (S1u02.3169;
Author Summary
Staphylococcus aureus is a bacterium that colonizes
humans worldwide. The anterior nares are its main
ecological niche. Carriers of S. aureus are at a higher risk
of developing invasive infections. Few reports indicated a
different clonal structure and profile of virulence factors in
S. aureus isolates from Sub-Saharan Africa. As there are no
data about isolates from remote indigenous African
populations, we conducted a cross-sectional survey of S.
aureus nasal carriage in Gabonese Babongo Pygmies. The
isolates were characterized regarding their susceptibility to
antibiotic agents, possession of virulence factors and
clonal lineage. While similar carriage rates were found in
populations of industrialized countries, isolates that
encode the genes for the Panton-Valentine leukocidin
(PVL) were clearly more prevalent than in European
countries. Of interest, many methicillin-susceptible S.
aureus isolates from Babongo Pygmies showed the same
genetic background as pandemic methicillin-resistant S.
aureus (MRSA) clones. We advocate a surveillance of S.
aureus in neglected African populations to control the
development of resistance to antibiotic drugs with
particular respect to MRSA and to assess the impact of
the high prevalence of PVL-positive isolates.
Staphylococcus aureus from African Pygmies
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(S1u01.6389;E11u08.1239). Allvillagers who hadbeeninthe villages
during our visit met the inclusion criteria (n=103). Three persons
from Egouba refused to participate. The age distribution of
participants showed a pagoda-shaped population pyramid with
45% of participants being #15 years old and 13% being $45 years
old (Figure 1). Overall, 46% of participants were female. Of all
participants, 65% have travelled at least to one of the nine capital
cities of Gabon since birth. Twenty-six percent (n=26) of the
population had been hospitalized previously in dispensaries or
primary-care hospitals (Table 1).
S. aureus carriage and antimicrobial resistance
Culture of 100 nasal swabs identified 34 S. aureus isolates. The
carriage rate was 33%. From one participant, two phenotypically
different S. aureus isolates were isolated (white colonies with b-
hemolysis and yellow-white colonies with faint b-hemolysis). Of all
carriers, 42.4% were females (OR =1.24, 95% CI =0.49–3.15;
p=0.62). Carriage differed between the five villages ranging from
0% (Ndougou, n=5 participants) to 45.7% (Village Tranquille,
n=46 participants, Table 1). There was an age-related carriage
pattern with a peak colonization of 53.9% in participants between
10 and 20 years of age and a decreasing prevalence in subsequent
age groups (Figure 1). No significant associations between S. aureus
carriage and any recorded risk factor were detected (not shown).
Of the totality of 34 S. aureus isolates, 64.7% (n=22) were
susceptible to penicillin, blaZ PCR amplicons were only detected
in penicillin resistant isolates (n=12). In addition, 94.1% (n=32)
were susceptible to tetracycline and 88.2% (n=30) to trimeth-
oprim-sulfamethoxazole. All isolates were susceptible to oxacil-
lin/methicillin, aminoglycosides, fluoroquinolones, macrolides,
lincosamides (including inducible clindamycin resistance), nitro-
furantoin, fosfomycin, rifampicin and vancomycin. Susceptibility
to oxacillin/methicillin was further confirmed by the absence of
mecA. Collecting and preparing medicinal herbs was not
significantly related to a lower prevalence of antibiotic resistance
(penicillin, tetracycline or trimethoprim-sulfamethoxazole) in
colonizing S. aureus isolates (OR =0.23, 95% CI 0.02–1.51,
p=0.078).
Virulence factors and agr groups
We detected 111 toxin encoding genes among 34 S. aureus
isolates indicating a high prevalence of toxin co-possession. Table 2
shows the prevalence of the virulence factors tested and assigns
these virulence factors to the total number of virulence genes,
which were simultaneously detected. Overall, 73.5% (n=25) of all
isolates encoded one or more PTSAgs, with co-possession found in
15 isolates including 15 isolates (44%) that encoded the linked seg-
sei loci. The tst gene was not detected but PVL-encoding genes
were found in 55.9% (n=19) of all isolates and were always co-
Figure 1. Pagoda-shaped population pyramid of the study population and S. aureus carriage rates (%) in different age groups. X-
axis indicates the percentage of male (M) and female (F) participants of the whole study population, y-axis represents age groups and the carriage
rate of S. aureus in the respective age group.
doi:10.1371/journal.pntd.0001150.g001
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seh and etd were always co-detected with PVL-encoding genes
(p=0.238 and p=0.113 respectively). Other virulence genes were
only partially co-detected with PVL: sea (80.0%, p=0.36), seb
(14.3%, p=0.03), seg/sei (60.0%, p=0.67), edin-B (75.0%,
p=0.63). PVL was not co-detected with sec (p=0.03) and eta
(p=0.44).
Among the accessory gene regulator subtypes, agr III was the
most prevalent (61.76%, n=21) followed by agr I and II (17.65%,
n=6 each) and agr IV (2.94%, n=1, Table 3). Isolates encoding
PVL-encoding genes were significantly less associated with agr I
(OR =0; 95% CI: 0–0.52, p=0.002) but often co-occurred with
agr III (OR =3.1, 95% CI: 0.62–17.29, p=0.107). sea was
significantly associated with agr II (OR =41.12, 95% CI: 2.74–
2679.92, p=0.002). There was no significant association of all
other virulence genes with any agr type.
Capsular polysaccharides
Detection of capsular polysaccharide (CP) encoding genes
revealed a high prevalence of type 8 (CP8, 82.4%, n=28)
followed by type 5 (CP5, 14.7%, n=5). One isolate was CP gene
non-typable (2.9%). Interestingly, the PVL-encoding genes were
co-detected with CP5 in 20% (OR =0.16, 95% CI 0–1.91,
p=0.146), and with CP8 in 64.3% (OR =8.44, 95% CI 0.79–
447.45, p=0.066). The heterogeneous distribution of CP was also
reflected by a significant association of CP5 with agr I (OR =
41.12, 95% CI 2.74–2679.92, p=0.002) and CP8 with agr III
(OR = infinity, 95% CI 2.6–infinity, p=0.001).
Table 1. Demographic characteristics of the Babongo population in the Ikobe ´ region, Gabon.
Demographic data
Village
Tranquille Tsibanga Ossimba Ndougou Soga Egouba Total
No. participants 46 15 19 5 13 2 100
Mean age in years (range) 21.7 (0.17–84) 23.0 (2–47) 22.4 (0.08–70) 31 (3–49) 30.8 (6–49) 37.5 (35–40) 23.8 (0.08–
84)
Female (%) 50 40 47.4 20 53.8 0 46
Mean weight (kg) 6SD 30.09616.67 39.49619.09 34.47618.82 46.66625.47 39.45611.25 48.3561.91 34.74617.64
Mean height (m) 6SD 1.1960.33 1.3860.26 1.2860.36 1.2860.27 1.4360.16 1.5360.04 1.2860.31
Travelling since birth (%) 73.9 53.3 57.9 40 61.5 100 65
Health care contact (%) 19.6 33.3 42,1 40 7.7 50 26
No. S. aureus carriers (%) 21 (45.7) 2 (13.3) 5 (26.3) 0 4 (30.8) 1 (50) 33
Penicillin resistance (%) 33.3 50.0 40.0 NA
a 40.0 0 35.3
Tetracycline resistance (%) 9.5 0 0 NA
a 0 0 5.8
Trimethoprim-sulfamethoxazole
resistance (%)
19.4 0 0 NA
a 0 0 11.8
spa type (%) t084 (19.1), t148
(9.5), t159 (4.8),
t1848 (33.3), t186
(14.3), t1931 (4.8),
t311 (4.8), t5941
(9.6)
t148 (50),
t570 (50)
t148 (20), t186
(20), t189 (20),
t1931 (20), t6020
(20)
NA
a t127 (20),
t189 (20),
t5941 (40),
t6025 (20)
t1848 (100)
anot applicable.
doi:10.1371/journal.pntd.0001150.t001
Table 2. Co-possession of virulence factor-encoding genes.
Toxin gene
Single
possession No. coexistent virulence factors (%) Total,
12345N o . ( % )
lukS-PV, lukF-PV (PVL) 0 2 (5.9) 6 (17.7) 7 (20.6) 3 (8.8) 1 (2.9) 19 (55.9)
sea 0 0 2 (5.9) 1 (2.9) 2 (5.9) 0 5 (14.7)
seb 0 4 (11.8) 0 2 (5.9) 1 (2.9) 0 7 (20.6)
sec 0 0 0 4 (11.8) 0 0 4 (11.8)
seg-sei 0 0 0 11 (32.4) 3 (8.8) 1 (2.9) 15 (44.1)
seh 0 0 3 (8.8) 0 0 0 3 (8.8)
eta 0 0 0 1 (2.9) 0 0 1 (2.9)
etd 0 0 1 (2.9) 2 (5.9) 0 1 (2.9) 4 (11.7)
edin-B 0 0 0 3 (8.8) 0 1 (2.9) 4 (11.7)
hlg 4 (11.8) 6 (17.7) 6 (17.7) 14 (41.2) 3 (8.8) 1 (2.9) 34 (100)
doi:10.1371/journal.pntd.0001150.t002
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We identified 13 different spa types among 34 S. aureus isolates
(Table 4). The most prevalent spa types were t1848 (23.5%, n=8),
t084, t148, t186 and t5941 (each 11.8%, n=4). One participant
carried two phenotypically different S. aureus isolates which had
different spa types (t6025, t5941). Three spa types (t5941, t6020,
t6025) have not been described before.
Ten different STs were found by MLST showing a Simpson’s
i n d e xo fd i v e r s i t y( 1 - D )o f0 . 8 9( T a b l e4 ) .A m o n gt h e s e ,ah i t h e r t o
unknown ST, designated ST1662 was detected. The most frequent
ST was ST30 (23.5%, n=8), exhibiting the following characteristics:
t1848, agr III, CP8 and lukS-PV/lukF-PV-positive. PVL-encoding
genes were found in isolates associated with spa types (ST) t1931
(ST1), t311 (ST5), t084 (ST15), t1848 (ST30), t5941 (ST80) and t159
(ST121, Table 4). STs did not cluster in distinct groups according to
eBURST analysis. Interestingly, when comparing the STs of this
study withthe whole MLSTdatabase, all theSTs of Babongo S. aureus
isolates represented the predicted founders of their respective clonal
complex, only the novel ST1662 was a singleton.
Inter-village variation
Detailed inter-village comparison revealed demographic differ-
ences between the six camp-like villages (Table 1). The number of
participants was imbalanced ranging from two in ‘‘Egouba’’ to 46
in ‘‘Village Tranquille’’ which is the biggest Babongo camp and
the residence of the Babongo leader in the Ikobe ´ region. Except
for ‘‘Egouba’’, resistance to penicillin was equally distributed
among isolates from different camps. Resistance to tetracyline and
trimethoprim-sulfamethoxazole was only found in ‘‘Village
tranquille’’ (Table 1). There was no predominance of a single
spa type or ST in a certain village. However, the following spa types
were only found in one village: t084, t159, t311 (‘‘Village
Tranquille’’), t570 (‘‘Tsibanga’’), t6020 (‘‘Ossimba’’) and t127,
t6025 (‘‘Soga’’, Table 1).
Discussion
To our knowledge, this is the first investigation of S. aureus
isolates from a semi-nomadic indigenous African population. It
provides a characterization of susceptibility to antimicrobial drugs,
virulence factors and the clonal structure of the isolates. The main
findings of our study are the high prevalence of PVL-positive
isolates and the same genetic background of Babongo S. aureus
isolates as pandemic clones.
Our survey needs to be considered as a representative
population-based study, because it covers more than 30% of the
Babongo population [21], has a balanced distribution of sex and
shows a pagoda-shaped population pyramid typical of a
developing community (Figure 1). Due to the semi-nomadic
lifestyle of the participants, we cannot give the exact total number
of the population in each village, but the total Pygmy population in
the study area is estimated to be 300 persons [21]. The S. aureus
carriage rate of 33% among Babongo Pygmies is similar to those
reported worldwide ranging from 25 to 35% [22,23]. Carriage
corrected for age groups showed the highest colonization in
teenagers (54%). This is comparable to the nasopharyngeal
carriage rate reported from Europe showing a peak prevalence
of over 50% at the age of ten years [24]. The absence of S. aureus in
Ndougou is probably due to the small sample size of this village
(n=5, Table 1) and the higher mean age of the participants as
carriage declines in older age groups (Figure 1).
Resistance to beta-lactams was rare. Only 35.3% of the isolates
were resistant to penicillin, no MRSA was detected. This high
prevalence of isolates susceptible to penicillin might be an indirect
Table 3. agr subtypes of S. aureus strains and number of co-
occurring virulence-genes.
agr subtype No. virulence factor encoding genes (%)
123456
agr I (n=6) 2 (33.3) 0 0 4 (66.7) 0 0
agr II (n=6) 1 (16.7) 0 2 (33.3) 1 (16.7) 2 (33.3) 0
agr III (n=21) 1 (4.8) 6 (28.6) 4 (19.1) 9 (42.9) 0 1 (4.8)
agr IV (n=1) 0 0 0 0 1 (100) 0
Total 4 6 6 14 3 1
doi:10.1371/journal.pntd.0001150.t003
Table 4. Molecular characteristics of S. aureus isolates from Babongo Pygmies.
Sequence
type (ST)
Clonal
complex (CC)
MLST allelic
profile spa type agr subtype
Capsular
type (CP)
lukS-PV,
lukF-PV (%)
No.
isolates
1 1 1-1-1-1-1-1-1 t1931 III 8 + (100) 2
1 1 1-1-1-1-1-1-1 t127 III 8 - (0) 1
5 5 1-4-1-4-12-1-10 t570 II nt
a -( 0 ) 1
5 5 1-4-1-4-12-1-10 t311 II 5 + (100) 1
15 15 13-13-1-1-12-11-13 t084 II 8 + (75%) 4
30 30 2-2-2-2-6-3-2 t1848 III 8 + (100) 8
72 72 1-4-1-8-4-4-3 t148 I 5 - (0) 4
80 80 1-3-1-14-11-51-10 t5941 III 8 + (100) 4
88 88 22-1-14-23-12-4-31 t186 III 8 - (0) 4
88 88 22-1-14-23-12-4-31 t6020 III 8 - (0) 1
121 121 6-5-6-2-7-14-5 t159 IV 8 + (100) 1
188 188 3-1-1-8-1-1-1 t189 I 8 - (0) 2
1662 singleton 3-1-6-19-13-13-11 t6025 III 8 - (0) 1
anot typeable.
doi:10.1371/journal.pntd.0001150.t004
Staphylococcus aureus from African Pygmies
www.plosntds.org 5 May 2011 | Volume 5 | Issue 5 | e1150marker of a limited use of antibiotic agents in this population.
However, community-associated MRSA (CA-MRSA) can also
emerge in remote populations as shown for Australian Aborigines
and North-American Indians [25–27]. The toxin gene profile
differed clearly from European carrier isolates. Whereas we
detected similar rates of sea, sec, seh and eta, the prevalence of genes
encoding other superantigens and exfoliative toxins were higher in
the Babongo S. aureus isolates compared to isolates originating
from Europe: seb (20.6 vs. 3.8%), etd (11.7 vs. 5.2%) and edin-B
(11.7 vs. 6.2%) [28]. Surprisingly, genes encoding SED-SEJ and
TSST-1, which are common among carrier and clinical isolates in
Europe (approx. 7–15% and 15–25% respectively) [14,28,29],
were not detected in this Pygmy population.
The distribution of the capsule types was biased towards CP8 vs.
CP5 (82.4% vs. 14.7%) compared to asymptomatic carriers in
Europe (approx. 60–75% vs. 10–35%) [23,30,31]. CP5 and CP8
have been shown to impact the virulence of S. aureus and the
clinical course of infection [32,33]. Capsular polysaccharide
expression is part of the agr regulon, we showed significant
association of CP5 with agr subtype I (p=0.002) and CP8 with agr
subtype II (p=0.001). This distribution of CP among agr subtypes
has also been shown in isolates derived from bovine mastitis [34].
Interestingly, more than 55% of the S. aureus isolated from
Babongo Pygmies carried PVL-encoding genes. This prevalence
is comparatively high as only 1–2% of clinical methicillin-
susceptible S. aureus (MSSA) isolates from Europe are PVL
positive [13,35]. PVL is a bacteriophage-encoded pore-forming
toxin, which causes necrosis of tissues and has cytocidal effects on
human neutrophils [1]. The clinical role of PVL is not yet fully
understood and its role as a virulence factor remains controver-
sial. PVL can be associated with necrotizing pneumonia in
humans [36]. A rabbit model of necrotizing pneumonia has
clearly demonstrated that PVL both activates polymorphnuclear
leucocytes (PMNs) and macrophages and induces necrosis of
PMNs [37]. Infected rabbits had the same clinical features of
necrotizing pneumonia as described in humans, i. e. lung necrosis,
edema, hemoptysis and death [37]. The high prevalence of PVL-
positive S. aureus strains could therefore be a risk for Babongo
Pygmies to develop necrotizing infections. However, studies with
different animal models have shown conflicting results concerning
the role of PVL. Some animal studies suggested PVL as major
virulence factor in a mouse pneumonia model [38]. Other studies
indicate that phenol soluble modulins might enhance the cytolytic
effect of PVL [39] or have shown that a-hemolysin (a-toxin) or a
point mutation in the agr P2 promoter are responsible for an
increased virulence of PVL-positive strains in mice [40,41]. In
addition, other experiments did not find any evidence for PVL as
a virulence factor in a murine model [42,43]. However, it is
known that PVL acts differentially on neutrophils of various
species as PVL has a strong cytotoxic effect on human neutrophils
but not on murine neutrophils [1]. Thus, the impact of a high
prevalence of PVL-positive strains in a healthy Babongo
population is still unclear. Further prospective studies are needed
to analyze if PVL has an impact on the incidence of S. aureus
infections in a neglected population.
Noteworthy, the presence of PVL-encoding genes was not
associated with one distinct clonal lineage, but was distributed
among different STs and spa types. A high prevalence of PVL
could be a common feature of Sub-Saharan S. aureus isolates as
high prevalence of PVL has been also found in non-pygmy
populations from South Africa (100%), Mali (100% in S. aureus
ST152), and Nigeria (42.7%) [3,7,44]. In contrast to our
investigation, all but one of these studies included clinical isolates
and might be therefore biased. However, high prevalence of PVL
encoding genes is frequently found in pandemic CA-MRSA-clones
and certain MSSA lineages (ST1, ST5, ST30, ST80) appear to be
a reservoir of CA-MRSA [6]. In our study, we found very
common STs (ST1, ST30, and ST121) amongst the Babongo
Pygmies, some of them are pandemic clones [6,45]. This is
surprising as the Babongo Pygmies split apart from other humans
at least 50,000 years ago and still live in isolated areas [46].
However, it is unclear, whether the same genetic background of
Babongo S. aureus isolates and pandemic clones reflects the global
spread of distinct clones or if it is the result of separate evolutionary
processes in different geographic regions where the same successful
clones were independently selected.
As shown for Helicobacter pylori, bacterial polymorphisms may
reflect human phylogeography and historical migrations [47]. The
genetic diversity in H. pylori decreases with geographic distance
from East Africa mirroring the migration of its human host [10].
Interestingly, the Simpson’s index of diversity among S. aureus STs
from Babongo Pygmies was higher (0.89) than in a comparably
remote Amerindian community in French Guiana (0.82), but was
still lower than in urban communities in France, Algeria, Moldavia
and Cambodia (0.92, 0.93, 0.92, 0.91) [8]. This is possibly due to a
higher exchange and transmission between people from different
regions and communities in the urban setting. Comparing genetic
diversity of S. aureus isolates from isolated population may
contribute to the discussion whether S. aureus shows a similar co-
evolution and phylogeographical distribution patterns as observed
for H. pylori [8,10]. To confirm this, more population-based carrier
studies are needed from different geographic regions to address
possible factors of S. aureus transmission between a given isolated
population and its neighboring communities.
One limitation of our study is the small sample size which might
be only increased if those inhabitants who went hunting in the
deep rain forest would have been included. Healthy male
subsistence hunter might therefore be underrepresented. In
addition, we failed to collect confident data about the use of
antimicrobial drugs to analyze its impact on the carriage of
resistant isolates. This limitation was due to a poor documentation
of antibiotic treatments in the personal health care files and due to
difficulty in recalling reliably the intake of antimicrobial agents.
Another limitation of our study is the missing data about the
incidence of S. aureus-related infections to assess the impact of the
high prevalence of PVL on developing invasive disease. To record
more confident data about the use of antibiotic drugs for each
participant and to survey the incidence of S. aureus infections,
future prospective studies are warranted.
In conclusion, our study provides the first insight in S. aureus
isolates from an African Pygmy population. While we found a high
prevalence of PVL-positive isolates, its impact on the incidence of
S. aureus infection in remote populations is not clear yet. Many S.
aureus isolates had the same genetic background as pandemic CA-
MRSA clones raising the question of a common ancestor. We
recommend a close surveillance of S. aureus isolates in remote
indigenous African population to control the emergence of
resistant isolates and to investigate the role of PVL-positive S.
aureus isolates in neglected communities.
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